On November 5th, the fifth China International Import Expo (CIIE) is set to open in Shanghai. This year, HTDK will collaborate with Software Medical Ltd, a global leader in energy-based, non-invasive medical aesthetic devices, to participate jointly in the event. Together, they will present cutting-edge innovations in the “Innovation Incubation Zone,” sharing the vast opportunities presented by China’s healthcare market.

At the fourth CIIE in 2021, HTDK’s joint innovation achievements and medical technology solutions created significant synergies within the Medical Device Innovation Incubation Zone. These included collaborations on the world’s first tabletop, cabinless, integrated pulmonary function testing (PFT) device for measuring lung volume, capacity, and gas diffusion (DLCO), the MINIBOX+ Pulmonary Function Testing System, Germany’s Implandata Eyemate for dynamic intraocular pressure monitoring, and Italy’s PERFORMER HT, an innovative oncology hyperthermia device. Initial cooperation agreements were reached with these innovative medical device manufacturers.

Since its debut at CIIE last year, HTDK has remained committed to the philosophy of “innovative healthcare, win-win cooperation.” Leveraging its leading industry expertise and innovative commercial services and solutions, the company is dedicated to introducing high-value, innovative medical devices into the Chinese healthcare market.

At the recent “Fifth CIIE Medical Device Professional Committee Open Innovation Symposium,” HTDK CEO, Ms. Cheng Xuehui, was invited to participate and expressed her appreciation for the Medical Innovation Incubation Zone at CIIE. She emphasized that CIIE serves as an important bridge for introducing international medical innovations and provides a one-stop resource docking opportunity for cutting-edge medical technologies. For HTDK, whose mission is to “serve global medical device brands and enhance the accessibility of global innovative medical devices in China,” CIIE offers significant opportunities and facilitates more efficient and reliable collaboration channels.

It was through this platform that HTDK engaged in multiple discussions with the Israeli Pulmone team in the Innovation Incubation Zone, ultimately securing exclusive distribution rights for the MINIBOX+ in China. The partnership is currently progressing smoothly.

HTDK is committed to bringing innovative global medical devices to the Chinese market, providing professional one-stop commercial solutions. The company has extensive experience in serving global brands in various specialized medical fields, including ophthalmology, in vitro diagnostics, orthopedics, cardiology, neurology, and vascular surgery. In addition to its strong foundation in these core areas, HTDK continues to explore new fields, staying ahead of market trends and identifying outstanding global products.

With the rapid advancement of innovative medical technologies, the aesthetic medicine sector has seen an influx of groundbreaking products in recent years. At this year’s CIIE, HTDK will collaborate with Sofwave Medical Ltd, a renowned global medical aesthetics brand from Israel. Visitors will have the opportunity to discover the breakthrough ultrasound treatment device, an innovative anti-aging product that demonstrates how “a simple approach can help people look younger.”

As a company with deep expertise in high-value medical devices, HTDK has long been dedicated to creating professional end-to-end solutions for bringing innovative international medical products to the Chinese market. At this year’s CIIE, HTDK will leverage its unique advantages in the commercialization of high-value medical devices in China, working alongside industry partners to introduce more cutting-edge technologies and innovations from abroad. Utilizing CIIE’s platform as an “innovation bridge,” HTDK aims to contribute to the “Healthy China” initiative, maximizing the benefits of collaboration for the country’s healthcare industry.

In addition, HTDK’s expertise in delivering professional, customized, and one-stop comprehensive commercial solutions, combined with its leading supply chain capabilities and cutting-edge technology, has resulted in a strategic partnership with BD, a Fortune 500 global medical technology giant. The two companies signed a strategic memorandum of understanding at CIIE, agreeing to collaborate on building a specialized market for Phasix hernia mesh, accelerating innovation, and bringing benefits to patients suffering from inguinal and abdominal wall hernias as soon as possible.